Castle Biosciences, Inc.
CSTL
$24.06
$0.502.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.52M | -25.85M | 9.59M | 2.27M | 8.92M |
| Total Depreciation and Amortization | 3.41M | 29.76M | 5.77M | 3.54M | 3.35M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.37M | 10.43M | 7.02M | 16.75M | 9.82M |
| Change in Net Operating Assets | 8.51M | -20.38M | 1.98M | 776.00K | 1.91M |
| Cash from Operations | 20.82M | -6.04M | 24.37M | 23.34M | 24.00M |
| Capital Expenditure | -9.26M | -4.74M | -7.57M | -6.38M | -5.23M |
| Sale of Property, Plant, and Equipment | 12.00K | 9.00K | 7.00K | 4.00K | 2.00K |
| Cash Acquisitions | -18.73M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -401.00K | -17.70M | 13.33M | -8.42M | -16.19M |
| Cash from Investing | -28.38M | -22.43M | 5.77M | -14.79M | -21.42M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -31.00K | -26.00K | -26.00K | -24.00K | -11.00K |
| Issuance of Common Stock | 531.00K | 988.00K | 1.02M | 2.16M | 668.00K |
| Repurchase of Common Stock | -589.00K | -2.52M | -6.38M | -1.29M | -615.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 190.00K | -- | -- | -- | -- |
| Cash from Financing | 101.00K | -1.55M | -5.39M | 838.00K | 42.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.46M | -30.02M | 24.75M | 9.39M | 2.62M |